cysteamine has been researched along with Edema in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (42.86) | 18.7374 |
| 1990's | 1 (7.14) | 18.2507 |
| 2000's | 1 (7.14) | 29.6817 |
| 2010's | 5 (35.71) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Athanasekou, C; Rekka, EA; Theodosis-Nobelos, P | 1 |
| Cha, HJ; Choi, SY; Choi, YJ; Eum, WS; Han, KH; Kim, DW; Lee, SH; Park, J; Shin, MJ | 1 |
| Cho, SB; Cho, YJ; Choi, SY; Choi, YJ; Eum, WS; Han, KH; Hwang, JS; Jo, HS; Kim, DS; Kim, DW; Kim, HA; Kim, JA; Lee, CH; Lee, KW; Park, J; Park, JH; Shin, MJ; Yeo, EJ; Yeo, HJ; Yong, JI | 1 |
| Cha, HJ; Choi, SY; Eum, WS; In Yong, J; Jeong, HJ; Jeong, JH; Kim, DS; Kim, DW; Kim, HC; Kim, SJ; Kwon, HY; Park, EY; Park, J; Park, JH; Park, M; Ryu, EJ; Shin, EJ; Yeo, HJ | 1 |
| Choi, SY; Hwang, HS; Jung, YO; Kim, DW; Kim, HA; Park, IY | 1 |
| Choi, SY; Hwang, HS; Kim, HA; Park, IY | 1 |
| Abdel-Salam, OM; Arbid, MS; Baiuomy, AR; El-Batran, S; El-Shenawy, SM | 1 |
| GOBLET, J; LECOMTE, J; VAN CAUWENBERGE, H; VLIERS, M | 1 |
| DOMENJOZ, R; MORSDORF, K; STENGER, EG; THEOBALD, W | 1 |
| BACQ, ZM; CESSION-FOSSION, A; LECOMTE, J; LIBON, JC | 1 |
| Ghanayem, BI; Maronpot, RR; Matthews, HB | 1 |
| Bacq, ZM; Beaumariage, ML; van Caneghem, P | 1 |
| Carminati, GM | 2 |
14 other study(ies) available for cysteamine and Edema
| Article | Year |
|---|---|
Dual antioxidant structures with potent anti-inflammatory, hypolipidemic and cytoprotective properties.
Topics: Acetaminophen; Animals; Anti-Inflammatory Agents; Antioxidants; Butanes; Carrageenan; Chemical and Drug Induced Liver Injury; Cysteine; Edema; Free Radicals; Hyperlipidemias; Lipid Peroxidation; Oxidative Stress; Parabens; Protective Agents; Rats | 2017 |
PEP-1-GLRX1 protein exhibits anti-inflammatory effects by inhibiting the activation of MAPK and NF-κB pathways in Raw 264.7 cells.
Topics: Animals; Anti-Inflammatory Agents; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cysteamine; Edema; Glutaredoxins; Inflammation; Lipopolysaccharides; Male; Mice; Mice, Inbred ICR; Mitogen-Activated Protein Kinases; NF-kappa B; Nitric Oxide Synthase Type II; Peptides; Phosphorylation; RAW 264.7 Cells; Signal Transduction; Tetradecanoylphorbol Acetate | 2020 |
PEP-1-PEA15 suppresses inflammatory responses by regulation of MAPK in macrophages and animal models.
Topics: Animals; Apoptosis Regulatory Proteins; Cysteamine; Cytokines; Disease Models, Animal; DNA Fragmentation; Edema; Extracellular Signal-Regulated MAP Kinases; Humans; Inflammation; Inflammation Mediators; Intracellular Signaling Peptides and Proteins; Lipopolysaccharides; Macrophages; Male; Mice; Mice, Inbred ICR; Peptides; Phosphoproteins; RAW 264.7 Cells; Reactive Oxygen Species; Signal Transduction; Tetradecanoylphorbol Acetate | 2018 |
Down-regulation of MAPK/NF-κB signaling underlies anti-inflammatory response induced by transduced PEP-1-Prx2 proteins in LPS-induced Raw 264.7 and TPA-induced mouse ear edema model.
Topics: Animals; Cell Line; Cysteamine; Ear; Edema; Gene Expression Regulation; Homeodomain Proteins; Macrophages; Male; Mice; Mice, Inbred ICR; Mitogen-Activated Protein Kinase Kinases; NF-kappa B; Nitric Oxide; Peptides; Pyridines; Signal Transduction | 2014 |
PEP-1-FK506BP12 inhibits matrix metalloproteinase expression in human articular chondrocytes and in a mouse carrageenan-induced arthritis model.
Topics: Animals; Arthritis; Carrageenan; Cartilage, Articular; Cells, Cultured; Chondrocytes; Cysteamine; Disease Models, Animal; Edema; Humans; Interleukin-1beta; Matrix Metalloproteinase 13; Mice; Mitogen-Activated Protein Kinases; NF-kappa B; Peptides; Recombinant Fusion Proteins; Tacrolimus Binding Protein 1A; Transduction, Genetic | 2015 |
PEP-1-GRX-1 Modulates Matrix Metalloproteinase-13 and Nitric Oxide Expression of Human Articular Chondrocytes.
Topics: Animals; Carrageenan; Cartilage, Articular; Cells, Cultured; Cysteamine; Disease Models, Animal; Down-Regulation; Edema; Glutaredoxins; Humans; Immunohistochemistry; Interleukin-1beta; Lipopolysaccharides; Male; Matrix Metalloproteinase 13; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinases; NF-kappa B; Nitric Oxide; Peptides; Recombinant Fusion Proteins; Signal Transduction | 2017 |
Studies on the anti-inflammatory and anti-nociceptive effects of melatonin in the rat.
Topics: Administration, Topical; Analgesics, Non-Narcotic; Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Cyclooxygenase Inhibitors; Cysteamine; Edema; Hindlimb; Indomethacin; Inflammation; Injections, Intraperitoneal; Lactones; Male; Melatonin; Pain; Pain Threshold; Rats; Rats, Sprague-Dawley; Sulfones; Tail | 2002 |
[Comparative inhibitory action of cysteinamine and of its derivatives on egg white edema in the rat].
Topics: Animals; Cysteamine; Cysteine; Edema; Egg White; Ethylamines; Rats | 1953 |
[Effect of cystinamine and cysteinamine on formalin edema and on cholesterol and ascorbic acid content of the adrenal glands in rats].
Topics: Adrenal Cortex; Adrenal Glands; Animals; Ascorbic Acid; Cholesterol; Cysteamine; Edema; Ethylamines; Formaldehyde; Rats | 1955 |
[ON SOME GENERAL PHARMACODYNAMIC EFFECTS OF CYSTAMINE IN THE RAT].
Topics: Adrenalectomy; Anti-Allergic Agents; Antihypertensive Agents; Bis-Trimethylammonium Compounds; Blood Pressure; Blood Pressure Determination; Bradykinin; Cystamine; Cysteamine; Dextrans; Edema; Guanethidine; Histamine H1 Antagonists; Histamine Release; Lysergic Acid Diethylamide; Norepinephrine; p-Methoxy-N-methylphenethylamine; Pertussis Vaccine; Pharmacology; Phentolamine; Promethazine; Rats; Research; Reserpine; Toxicology | 1964 |
Effects of sulfhydryl modulation on ethyl acrylate-induced forestomach toxicity.
Topics: Acrylates; Administration, Oral; Animals; Cysteamine; Cysteine; Dose-Response Relationship, Drug; Edema; Fasting; Male; Maleates; Mutagens; Rats; Rats, Inbred F344; Stomach Diseases | 1991 |
[Study of pharmacodynamic properties of cystamine and cysteamine in different animal species].
Topics: Animals; Blood Pressure; Capillary Permeability; Carotid Arteries; Cats; Chickens; Cystamine; Cysteamine; Edema; Female; Histamine Release; Homeostasis; Hypotension; Injections, Intraperitoneal; Injections, Intravenous; Jejunum; Lung; Male; Manometry; Methysergide; Mice; Nictitating Membrane; Rabbits; Serotonin; Skin | 1966 |
[Pharmacological actions interfering with the development of experimental inflammatory reactions].
Topics: Anesthetics, Local; Animals; Anti-Inflammatory Agents; Antimalarials; Carrageenan; Central Nervous System Stimulants; Cysteamine; Cysteine; Edema; Granuloma; Histamine H1 Antagonists; Inflammation; Muscles; Rats; Sodium; Succinylcholine | 1965 |
[Collateral pharmacological actions of cysteamine].
Topics: Animals; Cysteamine; Edema; Liver; Metabolism; Rats | 1965 |